Trial Information
Prospective Observational Study of Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function
Inclusion Criteria:
- Patients whose treatment is provided to Centre Oscar Lambret
- With a corpus uteri adenocarcinoma, no metastatic, treated by:
- Surgery and observation without complementary treatment or
- Surgery and adjuvant radiotherapy or
- Surgery and curietherapy of vaginal dome
- With a cervix carcinoma, stade IA2 to IIB proximal, treated by :
- External radiochemotherapy and curietherapy or
- Only surgery or
- Pre-surgical curietherapy and surgery
- Age > 18 years
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Toxicities including on sexual function
Outcome Description:
According to Lent-Soma, NCICTC-AE v3.0, Franco-Italian Glossary
Outcome Time Frame:
up to 3 years
Safety Issue:
No
Principal Investigator
Philippe NICKERS, MD
Investigator Role:
Study Director
Investigator Affiliation:
Oscar Lambret Center
Authority:
France: The Commission nationale de l’informatique et des libertés
Study ID:
SEXUTOX
NCT ID:
NCT01650987
Start Date:
May 2009
Completion Date:
December 2015
Related Keywords:
- Corpus Uteri Carcinoma
- carcinoma
- uterus
- Not metastatic
- Carcinoma
- Uterine Neoplasms